Code | 0429E | ||||||||||
MA number | 09/0261/07-S | ||||||||||
Product Form: | tbl ent 105x40 mg (fľ.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 31.07.2007 |
Pediatric warnings: | Yes |
PIL: |
|
SPC: |
|
Safety feature | Yes |
Data update: | 20.04.2022 |